Pressure for change: can we continue to ignore the lack of evidence for blood pressure augmentation to treat delayed neurological deficit following subarachnoid haemorrhage?
Main Authors: | O'Leary, R, Coles, JP, Prisco, L |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Springer Nature
2024
|
Similar Items
-
The costs and prognostic characteristics of ischaemic neurological deficit due to subarachnoid haemorrhage in the United Kingdom. Evidence from the MRC International Subarachnoid Aneurysm Trial.
by: Rivero-Arias, O, et al.
Published: (2009) -
Value of delayed MRI in angiogram-negative subarachnoid haemorrhage.
by: Woodfield, J, et al.
Published: (2014) -
Subarachnoid haemorrhage: managing complications.
by: Bostwick, J, et al.
Published: (2001) -
Delayed cerebral ischaemia after subarachnoid haemorrhage: looking beyond vasospasm.
by: Rowland, M, et al.
Published: (2012) -
The role of aquaporin-4 in subarachnoid haemorrhage
by: Tait, MJ
Published: (2011)